← Leaderboards
Nagaraj S. Nagathihalli
University Of Miami School Of Medicine
$1,533,188
Attributed
$1,533,188
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $357.8K · FY2016–25$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,533,188 · 3
By mechanism
R01$1,012,439 · 1
R21$367,249 · 1
R03$153,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Zhibin Chen$6,517,049
- Nouri Neamati$15,871,783
- Teresa A Zimmers$8,645,385
- Lina A Shehadeh$2,715,940
- Beatriz Mateo-Victoriano$98,512
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelTumorMalignant NeoplasmsMalignant Neoplasm Of PancreasMediatingPancreatic Ductal AdenocarcinomaPre-ClinicalIn VivoBindingAutomobile DrivingNovel Therapeutic InterventionOncogenicInfiltrationCytokineImmunotherapyKras2 GeneCellsAnti-Tumor Immune ResponseImmuneImmune Checkpoint InhibitorCheckpoint InhibitionInsightGeneticGenetically Engineered Mouse
Grant awards (7)
Impact of CREB-driven mechanism in shaping the tumor-immune landscape$357,796
R01 · FY2025 · CA · contact PI
Impact of CREB-driven mechanism in shaping the tumor-immune landscape$329,883
R01 · FY2024 · CA · contact PI
Impact of CREB-driven mechanism in shaping the tumor-immune landscape$324,760
R01 · FY2023 · CA · contact PI
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival$76,750
R03 · FY2021 · CA · contact PI
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival$76,750
R03 · FY2020 · CA · contact PI
Targeting cytokine mediated CREB activation in pancreatic cancer$166,931
R21 · FY2017 · CA · contact PI
Targeting cytokine mediated CREB activation in pancreatic cancer$200,318
R21 · FY2016 · CA · contact PI